Literature DB >> 31001213

Corrigendum: Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation.

Huimin Deng1, Siqi Yang1, Yucheng Zhang1, Kai Qian1, Zhaohui Zhang1, Yangyang Liu2, Ye Wang2, Yang Bai1, Hongying Fan3, Xinmei Zhao1, Fachao Zhi1.   

Abstract

[This corrects the article DOI: 10.3389/fmicb.2018.02976.].

Entities:  

Keywords:  Clostridium difficile; commensal bacteria; gut barrier; gut microbiota; next-generation probiotic

Year:  2019        PMID： 31001213      PMCID： PMC6454232          DOI： 10.3389/fmicb.2019.00601

Source DB:  PubMed          Journal:  Front Microbiol        ISSN： 1664-302X            Impact factor:   5.640


  4 in total

1.  Using next-generation sequencing to develop a Shigella species threshold and profile faecal samples from suspected diarrhoea cases.

Authors:  Ann Smith
Journal:  Folia Microbiol (Praha)       Date:  2021-02-10       Impact factor: 2.099

2.  The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.

Authors:  Nicholas A Lesniak; Alyxandria M Schubert; Kaitlin J Flynn; Jhansi L Leslie; Hamide Sinani; Ingrid L Bergin; Vincent B Young; Patrick D Schloss
Journal:  mBio       Date:  2022-07-20       Impact factor: 7.786

3.  Structure-Activity Relationship for the Picolinamide Antibacterials that Selectively Target Clostridioides difficile.

Authors:  Enrico Speri; Yuanyuan Qian; Jeshina Janardhanan; Cesar Masitas; Elena Lastochkin; Stefania De Benedetti; Man Wang; Valerie A Schroeder; William R Wolter; Allen G Oliver; Jed F Fisher; Shahriar Mobashery; Mayland Chang
Journal:  ACS Med Chem Lett       Date:  2021-05-07       Impact factor: 4.632

4.  Streptococcus pneumoniae Endopeptidase O Promotes the Clearance of Staphylococcus aureus and Streptococcus pneumoniae via SH2 Domain-Containing Inositol Phosphatase 1-Mediated Complement Receptor 3 Upregulation.

Authors:  Sijie Li; Hong Zhang; Jiangming Xiao; Taixian Yuan; Zhaoche Shu; Yajun Min; Wenchun Xu; Yibing Yin; Xuemei Zhang
Journal:  Front Cell Infect Microbiol       Date:  2020-07-17       Impact factor: 5.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.